Werewolf Therapeutics, Inc. (HOWL)
Overview
Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.
Related on NestLens
Last updated July 15, 2026
Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.
Last updated July 15, 2026